Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease | MicrobiomeTrials← Back to trialsNCT02447874
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2015-05Est. Completion: 2028-01
Enrollment target: 21 participants Locations- Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta, Georgia, United States
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta, Georgia, United States
Other microbiome trials you might be interested in
Sickle Cell Disease
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, group-sequential…
Birmingham, United StatesEst. completion Jul 23, 2027
Sickle Cell DiseaseBeta-thalassemia
This is a non-ablative (partial) stem cell transplant for patients with severe sickle cell disease or beta-thalassemia r…
Bethesda, United StatesEst. completion Jun 30, 2032